Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,765.42
(
-1.52%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
106.58
(
5.89%
)
Bitcoin
71,241.56
(
-3.65%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

midastouch017

Send PM Follow Ignore
Followers 144
Posts 27987
Boards Moderated 5
Alias Born 02/07/2004

midastouch017

Re: DewDiligence post# 7813

Thursday, 02/17/2005 5:18:12 AM

Thursday, February 17, 2005 5:18:12 AM

Post# of 257257
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) is down 1.4%. The company last night announced that it was exercising its option to invest in a joint venture with Gamida-Cell to develop and market StemEx, a leukemia and lymphoma treatment.

The announcement will probably also benefit Gamida-Cell's other shareholder, Elbit Medical Imaging (Nasdaq: EMITF; TASE: EMIT), which is up 2.5%.

Midas
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now